Literature DB >> 10432493

Messenger RNA editing of the human serotonin 5-HT2C receptor.

L W Fitzgerald1, G Iyer, D S Conklin, C M Krause, A Marshall, J P Patterson, D P Tran, G J Jonak, P R Hartig.   

Abstract

RNA encoding the rat serotonin 5-HT2C receptor undergoes editing whereby one to four adenosines are converted to inosines. This conversion can change up to three codons out of a stretch of five in the second intracellular loop of the receptor. RNA editing of the rat 5-HT2C receptor that changes all three codons was shown previously to alter intracellular signaling by 5-HT without changing its receptor-binding affinity. We analyzed 5-HT2C receptor editing in human brain and hypothalamic RNA samples and confirmed that all four adenosine editing sites observed in rat were also present in human samples. Additionally, we identified a novel editing site in the middle edited codon that extends the repertoire of 5-HT2C receptors by six additional protein isoforms. We observed that editing reduces both the binding affinity and functional potency of agonists for recombinant human 5-HT2C receptor isoforms. This effect on binding affinity was proportional to the agonist's intrinsic activity, with full agonists most affected, and antagonists showing no effect. These data suggest that RNA editing may alter coupling energetics within the ternary complex, thereby altering agonist binding affinities, G protein coupling, and functional responses. RNA editing may thus provide a novel mechanism for regulating 5-HT synaptic signaling and plasticity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432493     DOI: 10.1016/S0893-133X(99)00004-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  50 in total

1.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

Authors:  C X Chen; D S Cho; Q Wang; F Lai; K C Carter; K Nishikura
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

2.  Serotonin 2c receptor RNA editing in major depression and suicide.

Authors:  Rebecca Lyddon; Andrew J Dwork; Mehdi Keddache; Larry J Siever; Stella Dracheva
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

3.  Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene.

Authors:  Rachel Flomen; Joanne Knight; Pak Sham; Robert Kerwin; Andrew Makoff
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

Review 4.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 5.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

6.  Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Miku Aoki; Katsutoshi Taguchi; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2015-09-15       Impact factor: 3.444

Review 7.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

8.  Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing.

Authors:  Kazuya Iwamoto; Miki Bundo; Tadafumi Kato
Journal:  RNA       Date:  2005-10       Impact factor: 4.942

Review 9.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

10.  RNA Editing Dynamically Rewrites the Cancer Code.

Authors:  Violeta Rayon-Estrada; F Nina Papavasiliou; Dewi Harjanto
Journal:  Trends Cancer       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.